Kyodo Pharmaceutical: Announcement on the 2024 Interest Payment of Mutual Convertible Bonds
Kyodo Pharmaceutical: Announcement of Resolutions of the Second Meeting of the Third Board of Directors
Kyodo Pharmaceutical: Announcement of Resolutions of the Second Meeting of the Third Board of Supervisors
Kyodo Pharmaceutical: Third quarter report 2024
Kyodo Pharmaceutical: Announcement of Resolutions of the First Meeting of the Third Board of Supervisors
Kyodo Pharmaceutical: Announcement on the Election of Staff Representative Supervisors for the 3rd Board of Supervisors
Kyodo Pharmaceutical: Announcement of Resolutions of the First Meeting of the Third Board of Directors
Kyodo Pharmaceutical: Announcement on the completion of the election of the Board of Directors and the Board of Supervisors and the appointment of senior management
Kyodo Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Kyodo Pharmaceutical: Legal Opinion of Beijing Zhonglun (Wuhan) Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Hubei Kyodo Pharmaceutical Co., Ltd.
Kyodo Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2024
Kyodo Pharmaceutical: Announcement on the election of the board of directors for a new term
Kyodo Pharmaceutical: Independent Director Candidate Statement and Commitment (Ho Tak Leung)
Kyodo Pharmaceutical: Announcement on the election of the Supervisory Board for a new term
Kyodo Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Kyodo Pharmaceutical: Announcement of Resolutions of the 28th Meeting of the 2nd Board of Directors
Kyodo Pharmaceutical: Independent Director Nominee\'s Statement and Commitment (Qi Fei)
Kyodo Pharmaceutical: Announcement of Resolutions of the 20th Meeting of the 2nd Board of Supervisors
Kyodo Pharmaceutical: CITIC Securities Co., Ltd.\'s inspection opinion on Hubei Kyodo Pharmaceutical Co., Ltd.\'s new daily related transactions forecast in 2024
Kyodo Pharmaceutical: Independent Director Candidate Statements and Commitments (Long Ziwu)